Prolonged hemodynamic effects (12 hours) of orally administered sustained-release nitroglycerin. 1979

P Strumza, and M Rigaud, and R Mechmeche, and P Rocha, and M Baudet, and J Bardet, and J P Bourdarias

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010919 Placebos Any dummy medication or treatment. Although placebos originally were medicinal preparations having no specific pharmacological activity against a targeted condition, the concept has been extended to include treatments or procedures, especially those administered to control groups in clinical trials in order to provide baseline measurements for the experimental protocol. Sham Treatment
D003692 Delayed-Action Preparations Dosage forms of a drug that act over a period of time by controlled-release processes or technology. Controlled Release Formulation,Controlled-Release Formulation,Controlled-Release Preparation,Delayed-Action Preparation,Depot Preparation,Depot Preparations,Extended Release Formulation,Extended Release Preparation,Prolonged-Action Preparation,Prolonged-Action Preparations,Sustained Release Formulation,Sustained-Release Preparation,Sustained-Release Preparations,Timed-Release Preparation,Timed-Release Preparations,Controlled-Release Formulations,Controlled-Release Preparations,Extended Release Formulations,Extended Release Preparations,Slow Release Formulation,Sustained Release Formulations,Controlled Release Formulations,Controlled Release Preparation,Controlled Release Preparations,Delayed Action Preparation,Delayed Action Preparations,Formulation, Controlled Release,Formulations, Controlled Release,Prolonged Action Preparation,Release Formulation, Controlled,Release Formulations, Controlled,Sustained Release Preparation,Timed Release Preparation,Timed Release Preparations
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D005260 Female Females
D005996 Nitroglycerin A volatile vasodilator which relieves ANGINA PECTORIS by stimulating GUANYLATE CYCLASE and lowering cytosolic calcium. It is also sometimes used for TOCOLYSIS and explosives. Glyceryl Trinitrate,Anginine,Dynamite,Gilustenon,Nitrangin,Nitro-Bid,Nitro-Dur,Nitrocard,Nitroderm,Nitroderm TTS,Nitroglyn,Nitrol,Nitrolan,Nitrong,Nitrospan,Nitrostat,Perlinganit,Susadrin,Sustac,Sustak,Sustonit,Transderm Nitro,Tridil,Trinitrin,Trinitrolong,Nitro Bid,Nitro Dur,NitroBid,NitroDur,Trinitrate, Glyceryl
D006333 Heart Failure A heterogeneous condition in which the heart is unable to pump out sufficient blood to meet the metabolic need of the body. Heart failure can be caused by structural defects, functional abnormalities (VENTRICULAR DYSFUNCTION), or a sudden overload beyond its capacity. Chronic heart failure is more common than acute heart failure which results from sudden insult to cardiac function, such as MYOCARDIAL INFARCTION. Cardiac Failure,Heart Decompensation,Congestive Heart Failure,Heart Failure, Congestive,Heart Failure, Left-Sided,Heart Failure, Right-Sided,Left-Sided Heart Failure,Myocardial Failure,Right-Sided Heart Failure,Decompensation, Heart,Heart Failure, Left Sided,Heart Failure, Right Sided,Left Sided Heart Failure,Right Sided Heart Failure
D006439 Hemodynamics The movement and the forces involved in the movement of the blood through the CARDIOVASCULAR SYSTEM. Hemodynamic

Related Publications

P Strumza, and M Rigaud, and R Mechmeche, and P Rocha, and M Baudet, and J Bardet, and J P Bourdarias
September 1980, La Nouvelle presse medicale,
P Strumza, and M Rigaud, and R Mechmeche, and P Rocha, and M Baudet, and J Bardet, and J P Bourdarias
September 1986, The American journal of cardiology,
P Strumza, and M Rigaud, and R Mechmeche, and P Rocha, and M Baudet, and J Bardet, and J P Bourdarias
July 1971, Journal of pharmaceutical sciences,
P Strumza, and M Rigaud, and R Mechmeche, and P Rocha, and M Baudet, and J Bardet, and J P Bourdarias
January 2001, Anesthesiology,
P Strumza, and M Rigaud, and R Mechmeche, and P Rocha, and M Baudet, and J Bardet, and J P Bourdarias
January 1980, Chest,
P Strumza, and M Rigaud, and R Mechmeche, and P Rocha, and M Baudet, and J Bardet, and J P Bourdarias
May 1987, Clinical pharmacology and therapeutics,
P Strumza, and M Rigaud, and R Mechmeche, and P Rocha, and M Baudet, and J Bardet, and J P Bourdarias
September 1973, Angiology,
P Strumza, and M Rigaud, and R Mechmeche, and P Rocha, and M Baudet, and J Bardet, and J P Bourdarias
January 1997, Archivos de bronconeumologia,
P Strumza, and M Rigaud, and R Mechmeche, and P Rocha, and M Baudet, and J Bardet, and J P Bourdarias
September 1988, Circulation,
P Strumza, and M Rigaud, and R Mechmeche, and P Rocha, and M Baudet, and J Bardet, and J P Bourdarias
April 2005, American journal of veterinary research,
Copied contents to your clipboard!